The CeramTec Group has taken the next step in its transformation into a medtech company and acquired the Swiss specialist for ceramic dental implants, Dentalpoint AG.
The leading medical technology group is expanding its range as a supplier in the field of high-performance ceramics. The high-quality, biocompatible ceramic components for joint and dental implants from the CeramTec Group help patients around the world to improve their lives.
With the takeover of the Swiss Dentalpoint AG (“Dentalpoint”) on 4 January 2021, CeramTec is investing in the rapidly growing future market for metal-free dentures and thus, expanding its portfolio for medical technology applications.
As one of the leading suppliers in the field of metal-free, two-part ceramic implants, Dentalpoint makes a substantial contribution to the further development of implantology and has an established, innovative product platform.
The transaction creates a leading global provider of solutions in the field of ceramic dental implants that combine the highest product quality in terms of compatibility and aesthetics.
“With the acquisition, we are not only consistently expanding our portfolio in the medical segment, but also expanding our access to the dental market, product development expertise, and manufacturing capacities in a rapidly growing market environment,” said Hadi Saleh, CEO of the CeramTec Group.
Adrian Hunn, CEO of Dentalpoint AG, added, “Through the integration into the CeramTec Group, we expect new impulses for our existing business and the expansion of our international presence. Dentalpoint will remain on the market as a company with the established Zeramex brand and continue to expand.”
Dentalpoint has the latest production technology and automated manufacturing processes. For more than 10 years, customers have trusted the high-quality, customer-specific product solutions from Switzerland.
CeramTec has over 45 years of experience with high-performance ceramics for medical technology applications, which are used successfully worldwide for the benefit of patients. The ceramic implants from CeramTec are metal-free and have excellent biocompatibility, chemical stability, and high wear resistance. The proven expertise in materials and injection moulding enables, in particular, the cost-efficient manufacture of dental implants.
CeramTec received legal support from the law firm Homburger AG in Zurich, and Morgan Stanley as financial advisor.
